Search

Your search keyword '"Guttman, Cheryl"' showing total 7,462 results

Search Constraints

Start Over You searched for: Author "Guttman, Cheryl" Remove constraint Author: "Guttman, Cheryl"
7,462 results on '"Guttman, Cheryl"'

Search Results

1. 2009: a banner year in cataract surgery: approval of first femtosecond laser for cataract surgery among developments

2. Improved tools allow better care: progress in glaucoma follows a slow, steady course, according to specialists

3. Hyperopic shift biomechanical: refractive change in stage 4 DLK, CTK seen as inflammatory, cytokine-driven, reversible event

4. Glaucoma therapies, technology expand in '08

5. Cataract 2008: a year in review: numerous innovations, developments enhance surgery, patient outcomes

6. Debate continues on role of incision type in endophthalmitis risk

7. Glaucoma 2007: the year in review: specialists turn their focus to diagnostics, new surgical modalities

8. Ophthalmology responds to bevacizumab embargo

9. 2007 largely spectacular for cataract surgery: new technology, pharmaceuticals offer excitement despite fee-reduction worries

10. Advances seen in glaucoma evaluation, management: imaging technology improves as well as possible alternatives to trabeculectomy

11. Complications take center stage in cataract surgery arena: surgeons note TASS outbreak/prevention guidelines, continued awareness of IFIS

12. Ranibizumab launches new era for wet AMD

13. Virtual simulator being developed as training tool

14. FDA approves ophthalmic gel

15. Femtosecond laser enters new era

16. Mini-shunt, scleral flap provide glaucoma control: retrospective study documents long-term efficacy, safety of procedure used alone or with phaco

17. Microincisional IOL debuts: lens designed for delivery through 1.8-mm incision

18. Negative dysphotopsia an enigma: surgical strategies can ameliorate disturbing symptoms, however

19. Surgeon preference, patient-related factors guide choice between AC, suture-fixated PC IOLs

20. High-myopic LASIK sees long-term safety, efficacy: procedure's stability and predictability were less favorable, however

21. Dislocated IOLs managed with custom approach: lens exchange, repositioning offer improved acuity, low complication rate

22. XLT study results: BAK may not be the primary culprit in ocular adverse events with prostaglandin treatment: findings suggest factors other than exposure to the preservative contribute to side effects

24. Research sets stage for subtotal focal ablation of PCa: careful patient selection increases odds of positive outcomes, studies suggest

25. Favorable profile makes azithromycin a rationale choice for anterior and posterior blepharitis: evaluations by independent investigators showed drug was safe, well tolerated

26. Complication risks must be discussed with RLE patients

28. Adjuvant hormonal therapy: longer duration is better

29. Panel reaches consensus on IOP: differences from prevailing opinion highlighted

30. Immunotherapy fails to delay time to PSA failure

31. Epi-LASIK, advanced surface ablation, wavefront-guided procedures on rise: ASCRS survey divulges practice patterns, use of newer techniques, technologies

32. New formula allows, simplifies pseudophakic IOL power calculation

33. Biomarker changes may predict bladder Ca outcomes: post-op apoptotic protein changes appear linked to cancer recurrence, mortality risks

35. Large study supports combination phaco-ECP

36. Instrument cleaning, reprocessing implicated in reported TASS cases

37. BAK-free travoprost formulation approved

38. Prostate cancer treatment outcomes data take center stage

39. Low-vision care: ophthalmology's rehabilitation subspecialty

40. Botulinum toxin A shows efficacy in treating BPH

41. Second oral agent is approved for advanced RCC

42. Ranibizumab injections after PDT beneficial, interim trial finds

43. NSAID approved for cataract pain

44. Newer-generation formulation of levofloxacin provides option for bacterial corneal ulcers: fluoroquinolone provides broad-spectrum activity among infection strains

45. Cataract Outcomes Questionnaire helps assess functional vision: new tool considered a valid, reliable instrument that can be completed in 3 minutes

50. Investigators impressed by hydrophilic acrylic IOL outcomes: clinicians cite unique haptic design for providing exceptional centration and stability

Catalog

Books, media, physical & digital resources